David ShermanLifeSci Capital
Charles DuncanPiper Jaffray
Altimmune, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Altimmune, Inc. 's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Altimmune, Inc. or its management. Altimmune, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.